Masimo (MASI) Immaterializes SEDline (HSP) Acquisition (MASI, HSP)

Yesterday, Masimo Corporation MASI announced that the acquisition made by SEDline of brain monitoring system manufacturer Hospira, Inc. HSP is immaterial, as it is dilutive to 2010 EPS. However, they added, it makes strategic sense. Analysts at Morgan Keegan feel that Masimo will be able to use its brand-name and global sales-force in expanding the presence of SEDLine, as both their products are used by anaesthesiologists. Masimo has provided funds to SEDline in the form of $3 million in loans and $500,000 in cash to acquire IP. The analyst gave Outperform ratings to Masimo with Market Risk Suitability. See Some of the Top Moving Indexes Here.